Drugs / Trimethoprim/sulfamethoxazole
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT04285320 Comparator | Mar 2021 → Apr 2023 | urinary tract infection | Atlantic Health System | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Trimethoprim/sulfamethoxazole | “Trimethoprim/sulfamethoxazole daily (40 mg/200 mg)” NCT04285320 ↗ |
| Route | Oral | “In the antibiotic oral suppression therapy arm” NCT04285320 ↗ |